참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 6-Methoxy-5-(1-methyl-1H-pyrazol-4-yl)pyridin-2-ylamine | HCID 57512866 | — |
| 반응물 | (2R)-8-chloro-4-methyl-2-phenyl-3,5-dihydro-2H-pyrido[3,2-f][1,4]oxazepine | HCID 57512880 | — |
| 시약 | Potassium Carbonate | HCID 11430 | — |
| 촉매 | Binap, (A+-)- | HCID 634876 | — |
| 촉매 | Palladium (II) acetate | HCID 4144353 | — |
| 용매 | Toluene | HCID 1140 | — |
| 생성물 | gamma-Secretase modulator 6 | HCID 49819500 | 82.41% |
반응 단계
Charged a standard microwave vial with a mixture of 6-methoxy-5-(1-methyl-1H-pyrazol-4-yl)pyridin-2-amine (0.500 g, 2.45 mmol), (R)-8-chloro-4-methyl-2-phenyl-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepine (0.611 g, 2.22 mmol), palladium (II) acetate (0.015 g, 0.07 mmol), rac-BINAP (0.069 g, 0.11 mmol), potassium carbonate (0.461 g, 3.34 mmol), and toluene (20 mL). The atmosphere was inerted through consecutive vacuum-nitrogen purge cycles, then heated at 120 °C for 16 hours. HPLC-UV shows some starting materials remaining (<11% at 254 nm). The mixture was cooled to room temperature and 20 mL of DCM was added to the vessel. The pH was adjusted to pH 2 with 2.0N aqueous HCl and the phases were separated. Basified the aqueous with 2.0 M aqueous NaOH and extracted with 2 X 30 mL DCM. The organics were combined, dried with magnesium sulfate and concentrated by rotary evaporator to yield EN04092-36-001 (811 mg, 1.833 mmol, 82 %).
출처 및 근거
| 출처 데이터셋 | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-621d036677ca44618570da1795ad36a5 |
|---|
| 출처 메모 | 750 AstraZeneca ELN dataset |
|---|